Sugi Predict

Sugi Predict / Compounds / SCHEMBL4707488

SCHEMBL4707488

SCHEMBL4707488

CCn1nc(-c2ccc(F)cc2)c(C(C)=O)c(Nc2ccccc2F)c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.59
▸ TP53 P04637 2/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ ADRA1D P25100 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ ADRA1B P35368 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ KCNK3 O14649 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4708773 0.94 PDE4B (0.67) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL1652377 0.91 PDE4B (0.58) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL4707981 0.90 PDE4B (0.57) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL4706058 0.89 PDE4B (0.56) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL4706114 0.88 PDE4B (0.63) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL4708318 0.88 PDE4B (0.63) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL3037371 0.87 PDE4B (0.54) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL4706531 0.87 PDE4B (0.64) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL3033456 0.86 PDE4B (0.56) PDE4BTP53HTR1AADRA1DADRA1A
SCHEMBL3036245 0.86 PDE4B (0.53) PDE4BTP53SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459453-B2 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2008-12-02 — — US disclosed
US-20080269235-A1 PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS DAL PIAZ VITTORIO 2008-10-30 — — US disclosed
US-20060052379-A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2006-03-09 — — US disclosed
EP-1503992-A1 PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS Almirall Prodesfarma, S.A. (ES) 2005-02-09 — — EP disclosed
WO-2003097613-A1 PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS ALMIRALL PRODESFARMA SA (ES) 2003-11-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269235-A1 PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS PDE4A, PDE3A, PDE4B PDE4B 3/4885TP53 4836/4885HTR1A 1051/4885
US-20060052379-A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors PDE4A, PDE3A, PDE4B PDE4B 3/4885TP53 4836/4885HTR1A 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.